CORVUS PHARMACEUTICALS INC. - COMMON STOCK
9.1350
25-November-24 13:11:12
15 minutes delayed
Stocks
+0.1850
+2.07%
Today's range
8.9550 - 9.3529
ISIN
N/A
Source
NASDAQ
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 Aug 2021 16:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 Aug 2021 15:05:01 By Nasdaq GlobeNewswire
-
15 Jul 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 May 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 May 2021 08:00:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 Apr 2021 15:05:01 By Nasdaq GlobeNewswire
-
25 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 Feb 2021 15:10:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 Feb 2021 06:30:00 By Nasdaq GlobeNewswire